1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Human Growth Hormone Market in the US 2015-2019

Human Growth Hormone Market in the US 2015-2019

  • March 2015
  • -
  • Infiniti Research Limited
  • -
  • 84 pages

About Human Growth Hormone
Human growth hormone, also known as somatotropin, is a peptide with 191 amino acids and 2 sulfhydryl bridges. It is produced by the anterior pituitary, and it is required to attain normal size for children and adolescents. It also has major effects on lipid and carbohydrate metabolism of an individual. The effects of human growth hormone are mainly mediated by IGF-1 and IGF-2. There are two forms of recombinant human growth hormone approved in the market: Somatropin and Somatrem. Somatropin has 191 amino acids and Somatrem contains 192 amino acids. Growth hormone deficiency can occur either due to a damage to the pituitary or the hypothalamus gland, or can also be acquired genetically. Some of the signs of growth hormone deficiency are adiposity, short stature, and hypoglycemia.

TechNavio's analysts forecast the Human Growth Hormone market in the US to grow at a CAGR of 3.86 percent over the period 2014-2019.


Covered in this Report
This report covers the present scenario and the growth prospects of the Human Growth Hormone market in the US for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of the various human growth hormone drugs available in the US for the treatment of growth hormone deficiency.

TechNavio's report, the Human Growth Hormone Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the Human Growth Hormone market in the US and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.


Key Vendors
• F. Hoffmann-La Roche
• Merck Serono
• Novo Nordisk
• Pfizer

Other Prominent Vendors
• Eli Lilly
• Teva Pharmaceutical
• Novartis
• Ipsen


Market Driver
• Demand for Human Growth Hormone
• For a full, detailed list, view our report


Market Challenge
• High Cost of Therapy
• For a full, detailed list, view our report


Market Trend
• Growing Focus on Needle-free Drug Delivery Devices
• For a full, detailed list, view our report


Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Table Of Contents

Human Growth Hormone Market in the US 2015-2019
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Human Growth Hormone: An Overview
06.1 Human Growth Hormone
06.2 Pharmacological Action of Human Growth Hormone
06.3 Therapeutic Uses of Human Growth Hormone
06.4 Growth Hormone Deficiency
06.4.1 Childhood-onset Growth Hormone Deficiency
06.4.2 Adult-onset Growth Hormone Deficiency
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Trends and their Impact
15. Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Market Share Analysis 2014
15.2.1 Novo Nordisk
15.2.2 Pfizer
15.2.3 Merck Serono
15.2.4 F. Hoffmann-La Roche
15.3 Other Prominent Vendors
16. Key Vendor Analysis
16.1 F. Hoffmann-La Roche Ltd.
16.1.1 Key Facts
16.1.2 Business Overview
16.1.3 Business Segmentation
16.1.4 Business Segmentation by Revenue 2012 and 2013
16.1.5 Sales by Geography
16.1.6 Business Strategy
16.1.7 Key Information
16.1.8 SWOT Analysis
16.2 Merck Serono
16.2.1 Key Facts
16.2.2 Business Overview
16.2.3 Geographical Segmentation by Revenue 2013
16.2.4 Business Strategy
16.2.5 Recent Developments
16.2.6 SWOT Analysis
16.3 Novo Nordisk A/S
16.3.1 Key Facts
16.3.2 Business Overview
16.3.3 Business Segmentation by Revenue 2013
16.3.4 Business Segmentation by Revenue 2012 and 2013
16.3.5 Sales by Geography
16.3.6 Business Strategy
16.3.7 Key Information
16.3.8 SWOT Analysis
16.4 Pfizer
16.4.1 Key Facts
16.4.2 Business Overview
16.4.3 Business Segmentation by Revenue 2013
16.4.4 Business Segmentation by Revenue 2012 and 2013
16.4.5 Geographical Segmentation by Revenue
16.4.6 Business Strategy
16.4.7 Key Developments
16.4.8 SWOT Analysis
17. Other Reports in this Series


List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Structure of Human Growth Hormone
Exhibit 3: Clinical Uses of Recombinant Human Growth Hormone
Exhibit 4: Regulation of Human Growth Hormone and its Effects
Exhibit 5: Types of Growth Hormone Deficiency
Exhibit 6: Human Growth Hormone Market in US 2014-2019 (US$ million)
Exhibit 7: Drivers of Human Growth Hormone Market in US
Exhibit 8: NovoFine Needle
Exhibit 9: NordiPenMate
Exhibit 10: Challenges in Human Growth Hormone Market
Exhibit 11: Trends in Human Growth Hormone Market
Exhibit 12: Market Share of Vendors 2014
Exhibit 13: Comparison of Market Share of Major Drugs 2014 (US$ million)
Exhibit 14: YoY Global Revenue and Growth Rate of Norditropin 2012-2014 (US$ million)
Exhibit 15: Dosage Strengths of FlexPro
Exhibit 16: Dosage Strengths of NordiFlex
Exhibit 17: Dosage Strengths of Norditropin NordiLet
Exhibit 18: Dosage Strengths of Nordipen
Exhibit 19: Diagrammatic Illustration of Nordipen
Exhibit 20: Genotropin Miniquick
Exhibit 21: Diagrammatic Illustration of Genotropin Miniquick
Exhibit 22: Genotropin Mixer
Exhibit 23: Parts of Genotropin Mixer
Exhibit 24: Genotropin Pen
Exhibit 25: Diagrammatic Illustration of Genotropin Pen
Exhibit 26: YoY Global Revenue and Growth Rate of Genotropin 2011-2013 (US$ million)
Exhibit 27: YoY Global Revenue and Growth Rate of Saizen 2011-2013 (US$ million)
Exhibit 28: Diagrammatic Illustration of Click.easy
Exhibit 29: Easypod Drug Delivery Device
Exhibit 30: Diagrammatic Illustration of Cool.click 2
Exhibit 31: One.click Drug Delivery Device
Exhibit 32: Serojet Drug Delivery Device
Exhibit 33: YoY Global Revenue and Growth Rate of Nutropin 2010-2013 (US$ million)
Exhibit 34: Comparison of Global and US Revenue of Nutropin 2012 and 2013 (US$ million)
Exhibit 35: Diagrammatic Illustration of Nutropin AQ NuSpin
Exhibit 36: Nutropin AQ NuSpin 10
Exhibit 37: Nutropin AQ NuSpin 20
Exhibit 38: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 39: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2012 and 2013
Exhibit 40: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 41: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Diagnostics Division)
Exhibit 42: Merck Serono: Geographical Segmentation by Revenue 2013
Exhibit 43: Novo Nordisk A/S: Business Segmentation by Revenue 2013
Exhibit 44: Novo Nordisk A/S: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 45: Novo Nordisk A/S: Sales by Geography 2013
Exhibit 46: Pfizer: Business Segmentation by Revenue 2013
Exhibit 47: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 48: Pfizer: Geographical Segmentation by Revenue 2013

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Protein Therapeutics Market Analysis and Trends- Therapeutic Proteins (Bone morphogenetic proteins, Interferon (IFN), Insulin and Engineered protein scaffolds), Application (Cancer and Fertility), Function  - Forecast to 2025

Protein Therapeutics Market Analysis and Trends- Therapeutic Proteins (Bone morphogenetic proteins, Interferon (IFN), Insulin and Engineered protein scaffolds), Application (Cancer and Fertility), Function - Forecast to 2025

  • $ 4200
  • Industry report
  • November 2016
  • by Accuray Research LLP

The Global Protein Therapeutics Devices Market is poised to grow at a CAGR of around 8.6% over the next decade to reach approximately $315.90 billion by 2025. Some of the prominent trends that the market ...

Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis

Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis

  • $ 1350
  • Industry report
  • October 2016
  • by Igate Research

The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The ...

Global Biosimilar Market Outlook 2022

Global Biosimilar Market Outlook 2022

  • $ 1500
  • Industry report
  • September 2016
  • by RNCOS

A biosimilar is a biologic product that is similar to a regulatory body approved reference product, and has no clinically meaningful differences in terms of safety and effectiveness from that reference ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.